Consultative hemostasis and thrombosis / editors, Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle, David A. Garcia
"With authoritative coverage of rare and common hemostatic disorders, Consultative Hemostasis and Thrombosis, 4th Edition, keeps you both up to date with all that's new in this fast-moving field as well as reviewing background and development and citing pertinent classical literature. Broad differential diagnoses are provided, underscoring the editors' position that correct treatment begins with correct diagnosis"--Publisher's description.
Part 1: Hemorrhagic processes. Consultative process -- An approach to the bleeding patient: correlation of clinical symptoms and signs with laboratory testing -- Hemophilia A and B -- Less common congenital disorders of hemostasis -- Acquired coagulation disorders due to inhibitors -- von Willebrand disease -- General aspects of thrombocytopenia, platelet transfusions, and thrombopoietic growth factors -- Primary immune thrombocytopenia -- Congenital and acquired disorders of platelet function and number -- Purpura and other hematovascular disorders -- HHT -- Disseminated intravascular coagulation -- The cross-talk of inflammation and coagulation in infectious disease and their roles in disseminated intravascular coagulation -- Part 2: Thrombotic processes. Thrombophilia: clinical and laboratory assessment and management -- Pediatric aspects of thrombophilia -- Deep vein thrombosis, pulmonary embolism and primary pulmonary hypertension -- Venous thromboses at unusual sites -- The post thrombotic syndrome -- Thrombocytosis: essential thrombocytemia and reactive causes -- Antiphospholipid syndrome -- Antiplatelet treatment in cardiovascular medicine -- Non-arteriosclerotic arterial occlusive disease -- Thrombosis and cancer -- Thrombotic thrombocytopenic purpura -- Hemostatic disorders of complement activation (PNH and aHUS) -- Heparin-induced thrombocytopenia -- Part 3: Therapeutic agents. Antithrombotic agents -- Blood component and pharmacological agents -- Therapeutic apheresis: applications for hemorrhagic & thrombotic disorders -- Vena caval filters -- Part 4: Issues specific to women. Thrombotic risk of contraceptives and other hormonal therapies -- Bleeding and the management of hemorrhagic disorders in pregnancy -- Thrombophilia in pregnancy -- Part 5: Special issues. Surgery and hemostasis -- Anticoagulation in the perioperative period -- Understanding and managing the coagulopathy of liver disease -- Outpatient anticoagulant therapy -- Hematologic interventions for acute central nervous system disease -- Pending: atrial septal abnormalities and cryptogenic stroke -- Hemorrhage control and thrombosis following severe injury -- Hemostatic aspects of sickle cell disease.
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
Philadelphia, PA: Elsevier ; 2019 |
| Ausgabe: |
Fourth edition |
| Reproduktion: |
Online-Ausg. |
|---|
| Reihe: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Konkle, Barbara A. [HerausgeberIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| ISBN: |
|---|
| Anmerkungen: |
Includes bibliographical references and index Revised edition of: Consultative hemostasis and thrombosis / editors, Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle. 3rd ed. ©2013 |
|---|
| Umfang: |
1 Online-Ressource (xvi, 869 pages) ; color illustrations |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
1039899870 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 1039899870 | ||
| 003 | DE-627 | ||
| 005 | 20240422234342.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181106s2019 xxu|||||o 00| ||eng c | ||
| 020 | |a 0323477852 |c : electronic bk. |9 0-323-47785-2 | ||
| 020 | |a 0323477860 |c : electronic bk. |9 0-323-47786-0 | ||
| 020 | |a 9780323477857 |c : electronic bk. |9 978-0-323-47785-7 | ||
| 020 | |a 9780323477864 |c : electronic bk. |9 978-0-323-47786-4 | ||
| 035 | |a (DE-627)1039899870 | ||
| 035 | |a (DE-599)GBV1039899870 | ||
| 035 | |a (ELSEVIER)on1050449004 | ||
| 035 | |a (EBP)027278530 | ||
| 040 | |a DE-627 |b eng |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XD-US | ||
| 050 | 0 | |a RC647.C55 | |
| 060 | 0 | |a WH 322 | |
| 082 | 0 | |a 616.1/57 |2 23 | |
| 245 | 1 | 0 | |a Consultative hemostasis and thrombosis |c editors, Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle, David A. Garcia |
| 250 | |a Fourth edition | ||
| 264 | 1 | |a Philadelphia, PA |b Elsevier |c 2019 | |
| 300 | |a 1 Online-Ressource (xvi, 869 pages) |b color illustrations | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a ClinicalKey | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Revised edition of: Consultative hemostasis and thrombosis / editors, Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle. 3rd ed. ©2013 | ||
| 506 | |a Legal Deposit |e The Legal Deposit Libraries (Non-Print Works) Regulations (UK) | ||
| 520 | |a "With authoritative coverage of rare and common hemostatic disorders, Consultative Hemostasis and Thrombosis, 4th Edition, keeps you both up to date with all that's new in this fast-moving field as well as reviewing background and development and citing pertinent classical literature. Broad differential diagnoses are provided, underscoring the editors' position that correct treatment begins with correct diagnosis"--Publisher's description | ||
| 520 | |a Part 1: Hemorrhagic processes. Consultative process -- An approach to the bleeding patient: correlation of clinical symptoms and signs with laboratory testing -- Hemophilia A and B -- Less common congenital disorders of hemostasis -- Acquired coagulation disorders due to inhibitors -- von Willebrand disease -- General aspects of thrombocytopenia, platelet transfusions, and thrombopoietic growth factors -- Primary immune thrombocytopenia -- Congenital and acquired disorders of platelet function and number -- Purpura and other hematovascular disorders -- HHT -- Disseminated intravascular coagulation -- The cross-talk of inflammation and coagulation in infectious disease and their roles in disseminated intravascular coagulation -- Part 2: Thrombotic processes. Thrombophilia: clinical and laboratory assessment and management -- Pediatric aspects of thrombophilia -- Deep vein thrombosis, pulmonary embolism and primary pulmonary hypertension -- Venous thromboses at unusual sites -- The post thrombotic syndrome -- Thrombocytosis: essential thrombocytemia and reactive causes -- Antiphospholipid syndrome -- Antiplatelet treatment in cardiovascular medicine -- Non-arteriosclerotic arterial occlusive disease -- Thrombosis and cancer -- Thrombotic thrombocytopenic purpura -- Hemostatic disorders of complement activation (PNH and aHUS) -- Heparin-induced thrombocytopenia -- Part 3: Therapeutic agents. Antithrombotic agents -- Blood component and pharmacological agents -- Therapeutic apheresis: applications for hemorrhagic & thrombotic disorders -- Vena caval filters -- Part 4: Issues specific to women. Thrombotic risk of contraceptives and other hormonal therapies -- Bleeding and the management of hemorrhagic disorders in pregnancy -- Thrombophilia in pregnancy -- Part 5: Special issues. Surgery and hemostasis -- Anticoagulation in the perioperative period -- Understanding and managing the coagulopathy of liver disease -- Outpatient anticoagulant therapy -- Hematologic interventions for acute central nervous system disease -- Pending: atrial septal abnormalities and cryptogenic stroke -- Hemorrhage control and thrombosis following severe injury -- Hemostatic aspects of sickle cell disease | ||
| 533 | |a Online-Ausg. | ||
| 540 | |a Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force | ||
| 650 | 0 | |a Thrombosis |x Pathophysiology | |
| 650 | 0 | |a Hemostasis |x Physiological aspects | |
| 650 | 0 | |a Blood platelet disorders | |
| 650 | 0 | |a Fibrinolytic agents | |
| 650 | 0 | |a Anticoagulants (Medicine) | |
| 650 | 0 | |a Blood coagulation disorders | |
| 650 | 0 | |a Thrombosis |x Pathophysiology | |
| 650 | 0 | |a Hemostasis |x Physiological aspects | |
| 650 | 0 | |a Blood platelet disorders | |
| 650 | 0 | |a Fibrinolytic agents | |
| 650 | 0 | |a Anticoagulants (Medicine) | |
| 650 | 0 | |a Blood coagulation disorders | |
| 650 | 2 | |a Blood Platelet Disorders | |
| 650 | 2 | |a Blood Coagulation Disorders | |
| 650 | 2 | |a Hemostasis |x physiology | |
| 650 | 2 | |a Fibrinolytic Agents |x therapeutic use | |
| 650 | 2 | |a Anticoagulants |x therapeutic use | |
| 650 | 2 | |a Thrombosis |x pathology | |
| 650 | 2 | |a Anticoagulants | |
| 650 | 2 | |a Fibrinolytic Agents | |
| 650 | 4 | |a Anticoagulants (Medicine) | |
| 650 | 4 | |a Blood coagulation disorders | |
| 650 | 4 | |a Blood platelet disorders | |
| 650 | 4 | |a Fibrinolytic agents | |
| 650 | 4 | |a H�emostase - Aspect physiologique | |
| 650 | 4 | |a Thrombose - Physiopathologie | |
| 650 | 4 | |a Sang - Troubles de la coagulation | |
| 650 | 4 | |a Anticoagulants | |
| 650 | 4 | |a Sang - Troubles des plaquettes | |
| 650 | 4 | |a Fibrinolytiques | |
| 655 | 0 | |a Electronic books | |
| 700 | 1 | |a Konkle, Barbara A. |e herausgeberin |4 edt | |
| 700 | 1 | |a Kitchens, Craig S. |e herausgeberin |4 edt | |
| 700 | 1 | |a Kessler, Craig M. |e herausgeberin |4 edt | |
| 700 | 1 | |a Garcia, David Allen |e herausgeberin |4 edt | |
| 776 | 1 | |z 0323462022 | |
| 776 | 1 | |z 9780323462020 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |t Consultative hemostasis and thrombosis |d Philadelphia, PA : Elsevier, [2019] |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/book/9780323462020 |m X:ELSEVIER |x Verlag |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV-33-Freedom |b 2021 | ||
| 912 | |a GBV-33-EBS-ZHB | ||
| 912 | |a GBV-33-Freedom |b 2022 | ||
| 912 | |a ZDB-33-EBS | ||
| 912 | |a ZDB-33-ESD | ||
| 912 | |a GBV-33-EBS-MHH | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a ISIL_DE-18 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_22_i06404 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a ISIL_DE-354 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a ISIL_DE-841 | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 616.1/57 | ||
| 980 | |2 22 |1 01 |x 0018 |b 3578619833 |h h64 Elsevier |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y zi06404 |z 22-01-20 | ||
| 980 | |2 74 |1 01 |x 0354 |b 3563946612 |c 09 |f E-Bibl |d EK 0062 |e --%%-- |j --%%-- |h ACQ |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y ze |z 11-12-19 | ||
| 980 | |2 105 |1 01 |x 0841 |b 4074377373 |h ACQ |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y z |z 26-02-22 | ||
| 981 | |2 22 |1 01 |x 0018 |y Volltextzugang Campus |r http://www.sciencedirect.com/science/book/9780323462020 | ||
| 981 | |2 22 |1 01 |x 0018 |y Nur für Angehörige der Universität Hamburg: Volltextzugang von außerhalb des Campus |r http://emedien.sub.uni-hamburg.de/han/ScienceDirectBookseriesUKE/www.sciencedirect.com/science/book/9780323462020 | ||
| 981 | |2 74 |1 01 |x 0354 |y Volltext, Campuszugriff |r https://www.sciencedirect.com/science/book/9780323462020 | ||
| 981 | |2 74 |1 01 |x 0354 |y Volltext, Externer Zugriff |r http://mhh.hh-han.com/han/ebs/www.sciencedirect.com/science/book/9780323462020 | ||
| 981 | |2 105 |1 01 |x 0841 |r https://www.sciencedirect.com/science/book/9780323462020 | ||
| 985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
| 985 | |2 74 |1 01 |x 0354 |a EK 0062 | ||
| 985 | |2 74 |1 01 |x 0354 |a EM 4478 | ||
| 985 | |2 105 |1 01 |x 0841 |a 2021 E 121 | ||
| 995 | |2 22 |1 01 |x 0018 |a h64 Elsevier | ||
| 995 | |2 74 |1 01 |x 0354 |a ACQ | ||
| 995 | |2 74 |1 01 |x 0354 |a OLR-EBS | ||
| 995 | |2 105 |1 01 |x 0841 |a ACQ | ||
| 995 | |2 105 |1 01 |x 0841 |a OLR-ELV-ACQ | ||